Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5, signaling a minor software version update to the site's backend or UI.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a small maintenance update to the page's metadata. No substantive study content appears to be altered.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision metadata updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the Study Details page. This change appears to be a version bump rather than a substantive modification of the page content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision tag has been updated from v3.6.0 to v3.6.2, with the older tag removed. This update seems to reflect a backend or template change rather than a user-facing content modification.SummaryDifference0.0%

- Check63 days agoChange DetectedNew navigation items and help sections were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision note to v3.6.0. The recruitment status now shows no longer looking for participants.SummaryDifference0.5%

- Check70 days agoChange DetectedPage revision label updated from v3.5.4 to v3.5.5, indicating a minor revision of the document. This change signals a version bump and does not modify the stated study details or eligibility information.SummaryDifference0.0%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.